{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:33:02Z","timestamp":1788877982395,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020084","name":"Guangzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.intimp.2025.114215","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T21:44:27Z","timestamp":1738619067000},"page":"114215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["AGR, LMR and SIRI are the optimal combinations for risk stratification in advanced patients with non-small cell lung cancer following immune checkpoint blockers"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4660-6799","authenticated-orcid":false,"given":"Yun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biwen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8117-142X","authenticated-orcid":false,"given":"Jiajun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2008-7020","authenticated-orcid":false,"given":"Zexin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3733-9174","authenticated-orcid":false,"given":"Cunte","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guolong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7201-4928","authenticated-orcid":false,"given":"Peipei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2025.114215_b0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: profiles, trends, and determinants","volume":"135","author":"Xia","year":"2022","journal-title":"Chin. Med. J. (Engl)"},{"issue":"7","key":"10.1016\/j.intimp.2025.114215_b0010","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chin. Med. J. (Engl)"},{"issue":"8","key":"10.1016\/j.intimp.2025.114215_b0015","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","article-title":"Toward personalized treatment approaches for non-small- cell lung cancer","volume":"27","author":"Wang","year":"2021","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.114215_b0020","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41392-023-01700-4","article-title":"Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.intimp.2025.114215_b0025","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/modpathol.2017.54","article-title":"Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model","volume":"30","author":"Demicco","year":"2017","journal-title":"Mod. Pathol."},{"issue":"12","key":"10.1016\/j.intimp.2025.114215_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226765","article-title":"Predicting breast cancer risk using personal health data and machine learning models","volume":"14","author":"Stark","year":"2019","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.intimp.2025.114215_b0035","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10654-021-00752-6","article-title":"Systemic inflammation markers and cancer incidence in the UK Biobank","volume":"36","author":"N\u00f8st","year":"2021","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.intimp.2025.114215_b0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cca.2017.11.019","article-title":"Pretreatment albumin to globulin ratio can serve as a prognostic marker in human cancers: a meta-analysis","volume":"476","author":"Lv","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.intimp.2025.114215_b0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13048-019-0527-z","article-title":"Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: a meta-analysis","volume":"12","author":"Gong","year":"2019","journal-title":"J Ovarian Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.114215_b0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12894-020-00628-z","article-title":"Prognostic value of systemic inflammatory factors NLR, LMR, PLR and LDH in penile cancer","volume":"20","author":"Hu","year":"2020","journal-title":"BMC Urol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114215_b0055","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1620\/tjem.2023.J074","article-title":"Systemic Immune-Inflammation Index Predicts Tumor Recurrence after Radical Resection for Colorectal Cancer","volume":"261","author":"Nakamoto","year":"2023","journal-title":"Tohoku J. Exp. Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.114215_b0060","doi-asserted-by":"crossref","first-page":"837","DOI":"10.4103\/jcrt.JCRT_237_17","article-title":"The prognostic value of preoperative serum albumin-globulin ratio for high-grade bladder urothelial carcinoma treated with radical cystectomy: A propensity score-matched analysis","volume":"13","author":"Liu","year":"2017","journal-title":"J. Cancer Res. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2025.114215_b0065","doi-asserted-by":"crossref","first-page":"17272","DOI":"10.1038\/s41598-023-43391-5","article-title":"Preoperative albumin-to-globulin ratio and prognostic nutritional index predict the prognosis of colorectal cancer: a retrospective study","volume":"13","author":"Li","year":"2023","journal-title":"Sci. Rep."},{"issue":"9612","key":"10.1016\/j.intimp.2025.114215_b0070","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2025.114215_b0075","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-024-03735-7","article-title":"NRI and SIRI are the optimal combinations for prognostic risk stratification in patients with non-small cell lung cancer after EGFR-TKI therapy","author":"Liu","year":"2024","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.intimp.2025.114215_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1065345","article-title":"The derived neutrophil to lymphocyte ratio can be the predictor of prognosis for COVID-19 Omicron BA.2 infected patients","volume":"13","author":"Qiu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114215_b0085","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2147\/IJGM.S393263","article-title":"Prognostic Value of the Lung Immune Prognostic Index for Metastatic Non-Small Cell Lung Cancer Patients: A Chinese Cohort Study","volume":"16","author":"Huang","year":"2023","journal-title":"Int J Gen Med."},{"key":"10.1016\/j.intimp.2025.114215_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1129255","article-title":"The controlling nutritional status score predicts postoperative mortality in patients with ruptured abdominal aortic aneurysm: a retrospective study","volume":"10","author":"Ye","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.114215_b0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40164-021-00215-4","article-title":"Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients with diffuse large B-cell lymphoma","volume":"10","author":"Chen","year":"2021","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114215_b0100","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12943-024-02162-0","article-title":"Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL+\u2009leukemia stem cells","volume":"23","author":"Zeng","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2025.114215_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnves.2024.100002","article-title":"RNA-binding protein Roq modulates the Drosophila STING antiviral immune response","volume":"1","author":"Zheng","year":"2025","journal-title":"Cell Investigation."},{"key":"10.1016\/j.intimp.2025.114215_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnves.2024.100003","article-title":"Antioxidant dipeptide, cyclo (Phe-Phe), protects against bone dysplasia by suppression of phospholipid peroxidation","author":"Zhang","year":"2024","journal-title":"Cell Investigation."},{"issue":"8","key":"10.1016\/j.intimp.2025.114215_b0115","doi-asserted-by":"crossref","first-page":"953","DOI":"10.6004\/jnccn.2022.7021","article-title":"Perioperative Systemic Therapy for Resectable Non-Small Cell Lung Cancer","volume":"20","author":"Muthusamy","year":"2022","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"6","key":"10.1016\/j.intimp.2025.114215_b0120","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1200\/JCO.21.01497","article-title":"First-Line Immunotherapy for Non-Small-Cell Lung Cancer","volume":"40","author":"Reck","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.intimp.2025.114215_b0125","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.mayocp.2019.01.013","article-title":"Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment","volume":"94","author":"Duma","year":"2019","journal-title":"Mayo Clin. Proc."},{"issue":"1","key":"10.1016\/j.intimp.2025.114215_b0130","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12943-024-02099-4","article-title":"LAMTOR1 decreased exosomal PD-L1 to enhance immunotherapy efficacy in non-small cell lung cancer","volume":"23","author":"Wu","year":"2024","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2025.114215_b0135","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/ajcn\/82.4.777","article-title":"Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients","volume":"82","author":"Bouillanne","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.intimp.2025.114215_b0140","article-title":"Systemic Immune-Inflammation Index Is Associated With Increased Urinary Albumin Excretion: A Population-Based Study","volume":"13","author":"Qin","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114215_b0145","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3390\/nu13061980","article-title":"The Spectrum of Malnutrition\/Cachexia\/Sarcopenia in Oncology According to Different Cancer Types and Settings: A Narrative Review","volume":"13","author":"Bossi","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.intimp.2025.114215_b0150","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/0148607113502674","article-title":"Prevalence of malnutrition and current use of nutrition support in patients with cancer","volume":"38","author":"H\u00e9buterne","year":"2014","journal-title":"JPEN J. Parenter. Enteral Nutr."},{"issue":"45","key":"10.1016\/j.intimp.2025.114215_b0155","doi-asserted-by":"crossref","first-page":"79884","DOI":"10.18632\/oncotarget.20168","article-title":"Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study","volume":"8","author":"Muscaritoli","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.intimp.2025.114215_b0160","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/s41430-020-0629-0","article-title":"Relationship between markers of malnutrition and clinical outcomes in older adults with cancer: systematic review, narrative synthesis and meta-analysis","volume":"74","author":"Bullock","year":"2020","journal-title":"Eur. J. Clin. Nutr."},{"issue":"7203","key":"10.1016\/j.intimp.2025.114215_b0165","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.114215_b0170","article-title":"A Low Albumin-to-Globulin Ratio Predicts a Poor Prognosis in Patients With Metastatic Non-small-cell Lung Cancer","volume":"8","author":"Lu","year":"2021","journal-title":"Front Med (lausanne)."},{"issue":"10","key":"10.1016\/j.intimp.2025.114215_b0175","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1159\/000501726","article-title":"Prognostic Value of Pretreatment Lymphocyte-to-Monocyte Ratio in Non-Small Cell Lung Cancer: A Meta-Analysis","volume":"42","author":"Wang","year":"2019","journal-title":"Oncol. Res. Treat."},{"issue":"14","key":"10.1016\/j.intimp.2025.114215_b0180","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1002\/cncr.30057","article-title":"A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy","volume":"122","author":"Qi","year":"2016","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2025.114215_b0185","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jos.2020.11.006","article-title":"Systemic inflammation response index (SIRI) as a predictive factor for overall survival in advanced soft tissue sarcoma treated with eribulin","volume":"27","author":"Kobayashi","year":"2022","journal-title":"J. Orthop. Sci."},{"issue":"20","key":"10.1016\/j.intimp.2025.114215_b0190","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.21037\/atm-20-6484","article-title":"Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: a two-center retrospective study","volume":"8","author":"Hu","year":"2020","journal-title":"Ann Transl Med."},{"issue":"8","key":"10.1016\/j.intimp.2025.114215_b0195","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How to build and interpret a nomogram for cancer prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114215_b0200","doi-asserted-by":"crossref","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","article-title":"Non-Small Cell Lung Cancer, Version 4.2024","volume":"22","author":"Riely","year":"2024","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"4","key":"10.1016\/j.intimp.2025.114215_b0205","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.3747\/co.27.6049","article-title":"Real-world treatment patterns and survival in stage IV non-small-cell lung cancer in Canada","volume":"27","author":"Seung","year":"2020","journal-title":"Curr. Oncol."},{"issue":"10","key":"10.1016\/j.intimp.2025.114215_b0210","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002836","article-title":"Increased coexpression of PD-L1 and TIM3\/TIGIT is associated with poor overall survival of patients with esophageal squamous cell carcinoma","volume":"9","author":"Wang","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2025.114215_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnves.2024.100004","article-title":"Increased co-expression of CTLA4\/LAG3 predicted adverse clinical outcomes in patients with T-cell malignancies","volume":"1","author":"Wang","year":"2025","journal-title":"Cell Investigation."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692500205X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692500205X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T01:02:38Z","timestamp":1740618158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692500205X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":43,"alternative-id":["S156757692500205X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114215","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AGR, LMR and SIRI are the optimal combinations for risk stratification in advanced patients with non-small cell lung cancer following immune checkpoint blockers","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114215"}}